TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12909493

Group type: EXPERIMENTAL
Intervention: Uterosacral ligament resection
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conservative surgery
Number of subjects: 180
Study: 10563709

Group type: EXPERIMENTAL
Intervention: Lamivudine 150 mg twice a day
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Lamivudine 300 mg twice a day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Lamivudine 150 mg and 300 mg regimens
Number of subjects: 10
Study: 9494257

Group type: EXPERIMENTAL
Intervention: Amtolmetin guacyl (1200 mg/day for first 3 days, then 600 mg/day for remaining 27 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diclofenac (150 mg/day in three daily administrations on a full stomach)
Number of subjects: 50
Study: 8372257

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Metamizole
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 150
Study: 3787553

Group type: EXPERIMENTAL
Intervention: Coded peak flow meter
Number of subjects: 12

Group type: COMPARATOR
Intervention: Uncoded peak flow meter
Number of subjects: 12
Study: 29301477

Group type: EXPERIMENTAL
Intervention: EUS-guided reverse bevel fine-needle biopsy sampling (EUS-FNB)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional fine-needle aspiration (EUS-FNA)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: EUS-FNA + FNB
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: EUS-FNB and EUS-FNA
Number of subjects: 68
Study: 26446702

Group type: EXPERIMENTAL
Intervention: Cool pad pillow topper (CPPT) + standard care
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 74
Study: 23877124

Group type: EXPERIMENTAL
Intervention: 1-year lifestyle intervention with an early weight loss programme
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine lifestyle counselling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 60
Study: 22424397

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) program including Spirometry Fundamentals™ CD‐ROM, interactive webinars, and internet-based feedback system
Number of subjects: 36
Study: 20060298

Group type: EXPERIMENTAL
Intervention: Overground walking
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Treadmill walking while holding a handrail
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Treadmill walking without using a handrail
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: General recommendation
Number of subjects: 16
Study: 18713921

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (5 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch (5-15 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16132797

Group type: EXPERIMENTAL
Intervention: Fecal occult blood screening
Number of subjects: 2915

Group type: EXPERIMENTAL
Intervention: Screening sigmoidoscopy
Number of subjects: 2915

Group type: EXPERIMENTAL
Intervention: Screening colonoscopy
Number of subjects: 2915

Group type: EXPERIMENTAL
Intervention: Either screening endoscopy (fecal occult blood screening or sigmoidoscopy)
Number of subjects: 2915
Study: 12209274

Group type: EXPERIMENTAL
Intervention: PercuTwist technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Blue Rhino technique
Number of subjects: 70
Study: 10472510

Group type: EXPERIMENTAL
Intervention: High-dose (25 mg) nicotine patch therapy
Number of subjects: 408

Group type: COMPARATOR
Intervention: Standard-dose (15 mg) nicotine patch therapy
Number of subjects: 408
Study: 8943121

Group type: EXPERIMENTAL
Intervention: Early repair (within 4 hours of admission)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Delayed repair (more than 24 hours after birth)
Number of subjects: 54
Study: 8117635

Group type: EXPERIMENTAL
Intervention: 20 ml 0.5% bupivacaine with epinephrine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 22
Study: 3767037

Group type: EXPERIMENTAL
Intervention: Ketamine (1 mg X kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Droperidol (0.1 mg X kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30100317

Group type: EXPERIMENTAL
Intervention: Lip Closure Training (LCT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 26472043

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) with loading dose (400 mg Weeks 0/2/4)
Number of subjects: 338

Group type: COMPARATOR
Intervention: Certolizumab pegol (CZP) without loading dose
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) with loading dose
Number of subjects: 338
Study: 24798614

Group type: EXPERIMENTAL
Intervention: First-line antiretroviral therapy (efavirenz or nevirapine with zidovudine/lamivudine or tenofovir/lamivudine)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Zidovudine regimen (less than 1 year)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Zidovudine regimen (greater than 1 year)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: First-line antiretroviral therapy (in Nigeria)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Zidovudine regimen (in Nigeria)
Number of subjects: 650
Study: 23169985

Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading followed by 90 mg bid
Number of subjects: 55

Group type: COMPARATOR
Intervention: Prasugrel 60 mg loading followed by 10 mg od
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 55

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ticagrelor and Prasugrel
Number of subjects: 55
Study: 20448066

Group type: EXPERIMENTAL
Intervention: Random urine albumin-creatinine ratio (ACR)
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Timed urine albumin excretion rate (AER)
Number of subjects: 1186

Group type: EXPERIMENTAL
Intervention: Estimated AER (eAER) derived from ACR
Number of subjects: 1186

Group type: COMPARATOR
Intervention: DCCT intensive diabetes therapy
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Conventional diabetes therapy
Number of subjects: 1186
Study: 18350462

Group type: EXPERIMENTAL
Intervention: Stationary bicycle
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treadmill
Number of subjects: 80
Study: 15699654

Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 27
Study: 16388267

Group type: EXPERIMENTAL
Intervention: 25 gauge Quincke spinal needle
Number of subjects: 60

Group type: COMPARATOR
Intervention: 26 gauge Eldor spinal needle
Number of subjects: 60
Study: 10226872

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (4 x 200 mg/day, p.o.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 8709351

Group type: EXPERIMENTAL
Intervention: Neoadjuvant androgen withdrawal with 300 mg cyproterone acetate daily for 12 weeks
Number of subjects: 213

Group type: COMPARATOR
Intervention: Radical prostatectomy alone
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Neoadjuvant androgen withdrawal
Number of subjects: 213
Study: 1826175

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 111
Study: 7336470

Group type: EXPERIMENTAL
Intervention: Aluminum‐magnesium hydroxide (AMH)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (CC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide‐magnesium trisilicate (AHMT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Phenytoin alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cumulative urinary 5‐(4‐hydroxyphenyl)‐5‐phenylhydantoin at 72 hr (HPPH72)
Number of subjects: 8
Study: 31057021

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 716

Group type: COMPARATOR
Intervention: No job adjustments
Number of subjects: 716

Group type: COMPARATOR
Intervention: Any pain in the pelvic girdle
Number of subjects: 716

Group type: COMPARATOR
Intervention: Anterior pelvic pain
Number of subjects: 716

Group type: COMPARATOR
Intervention: Posterior pelvic pain
Number of subjects: 716
Study: 28646892

Group type: EXPERIMENTAL
Intervention: Waking up the spirit acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hand and foot 12-meridian acupuncture
Number of subjects: 60
Study: 26001387

Group type: EXPERIMENTAL
Intervention: Citalopram (30 mg single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 23901669

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab (Avastin)
Number of subjects: 150
Study: 22789792

Group type: EXPERIMENTAL
Intervention: Aromatherapy (inhalation group or aromatherapy hand technique) with essential oil blend of rose otto and lavandula angustifolia @ 2% dilution, 15 min sessions, twice a week for four weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (non-randomized, instructed to avoid aromatherapy)
Number of subjects: 28
Study: 19165115

Group type: EXPERIMENTAL
Intervention: Naltrexone treatment for 2 weeks
Number of subjects: 19
Study: 17565326

Group type: EXPERIMENTAL
Intervention: Alemtuzumab induction with tacrolimus monotherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Thymoglobulin induction with tacrolimus, mycophenolate, and steroids
Number of subjects: 21
Study: 15030964

Group type: EXPERIMENTAL
Intervention: Weight stabilisation (<= 1 kg lost) after an 8 week nutrition intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Weight losing (> 1 kg lost)
Number of subjects: 107
Study: 11473908

Group type: EXPERIMENTAL
Intervention: Webster‐Stratton basic videotape programme administered to parents of six to eight children over 13‐16 weeks
Number of subjects: 141

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Webster‐Stratton basic videotape programme
Number of subjects: 141
Study: 9870319

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zidovudine plus didanosine (ZDV + ddI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) therapy duration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Viral burden measurement
Number of subjects: 0
Study: 7851513

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the motor cortex
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cortical stimulation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cortical stimulation in patients with complete Bell's palsy
Number of subjects: 12
Study: 3132574

Group type: EXPERIMENTAL
Intervention: met‐hGH in postabsorptive state
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: met‐hGH in intravenous feeding
Number of subjects: 10
Study: 31599561

Group type: EXPERIMENTAL
Intervention: Postoperative hypocalcemia (<8.5 mg/dL)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Severe hypocalcemia (<7.5 mg/dL)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Longer operative time
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Postoperative calcium and magnesium levels correlation
Number of subjects: 285
Study: 28665377

Group type: EXPERIMENTAL
Intervention: Pharmacopuncture treatment with anti-homotoxic agents (placental compositum, co-enzyme compositum, ubichinon compositum)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Standard treatment including histamine H2-receptor antagonists, proton pump inhibitors, stimulators of gastrointestinal motility, alginates, and other drugs
Number of subjects: 290
Study: 25775048

Group type: EXPERIMENTAL
Intervention: Multimodal targeted infection program (TIP)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 418
Study: 23708720

Group type: EXPERIMENTAL
Intervention: Early rehabilitation program (n = 52)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional care (n = 46)
Number of subjects: 98
Study: 21348539

Group type: EXPERIMENTAL
Intervention: Vicriviroc with ritonavir and protease inhibitors (fixed-sequence studies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vicriviroc with or without lopinavir, zidovudine/lamivudine, and tenofovir disoproxil fumarate (parallel-group studies)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vicriviroc with other antiretroviral agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vicriviroc and combination treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vicriviroc co-administered with antiretroviral agents
Number of subjects: 0
Study: 18509176

Group type: EXPERIMENTAL
Intervention: Docetaxel therapy in ER-positive patients
Number of subjects: 3329

Group type: EXPERIMENTAL
Intervention: Docetaxel therapy in ER-negative patients
Number of subjects: 3329

Group type: COMPARATOR
Intervention: Docetaxel therapy
Number of subjects: 3329
Study: 16971709

Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Program (MLP)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 279
Study: 12657917

Group type: EXPERIMENTAL
Intervention: Dilantin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Epsolin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: M-toin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Eptoin
Number of subjects: 12
Study: 10737286

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone 20 mg
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone (mean dose approximately 40 mg/d after titration)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Controlled-release oxycodone
Number of subjects: 133
Study: 8762741

Group type: EXPERIMENTAL
Intervention: District drug formulary
Number of subjects: 50
Study: 1412653

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 2881964

Group type: EXPERIMENTAL
Intervention: DN-1417
Number of subjects: 12

Group type: COMPARATOR
Intervention: DT gamma E
Number of subjects: 12
Study: 31300493

Group type: EXPERIMENTAL
Intervention: NRT patches
Number of subjects: 884

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 884
Study: 27824661

Group type: EXPERIMENTAL
Intervention: Fecal immunochemical test (FIT)
Number of subjects: 4165

Group type: EXPERIMENTAL
Intervention: Flexible sigmoidoscopy (FS)
Number of subjects: 4165

Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 4165
Study: 26427305

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 80
Study: 23994101

Group type: EXPERIMENTAL
Intervention: First TKA
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Second TKA
Number of subjects: 30
Study: 22696995

Group type: EXPERIMENTAL
Intervention: Dynesys posterior stabilization
Number of subjects: 53

Group type: COMPARATOR
Intervention: Posterior lumbar interbody fusion (PLIF)
Number of subjects: 53
Study: 20099349

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid (0.025 mmol/kg body weight)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Gadobenate dimeglumine (0.05 mmol/kg body weight)
Number of subjects: 295
Study: 18050628

Group type: EXPERIMENTAL
Intervention: 20 min acupuncture treatment
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 40 min acupuncture treatment
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 60 min acupuncture treatment
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (all groups)
Number of subjects: 251

Group type: COMPARATOR
Intervention: 60 min group vs 20 min and 40 min groups
Number of subjects: 251

Group type: COMPARATOR
Intervention: 40 min group vs 20 min group
Number of subjects: 251
Study: 15929963

Group type: EXPERIMENTAL
Intervention: Reactance (X(rs)) measured by forced oscillometry
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Reactance (X(rs))
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Predicted R(L) from X(rs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: X(rs) in subjects with other respiratory conditions
Number of subjects: 40
Study: 12593524

Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) suspension for nebulization 3,000-4,000 microg/day b.i.d. via nebulizer
Number of subjects: 124

Group type: COMPARATOR
Intervention: Beclometasone dipropionate (BDP) spray 1,500-2,000 microg/day b.i.d. via metered-dose inhaler (MDI) plus spacer
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 124
Study: 10560993

Group type: EXPERIMENTAL
Intervention: Laparoscopic dye (LD) studies
Number of subjects: 278

Group type: COMPARATOR
Intervention: Selective salpingography (SS)
Number of subjects: 278
Study: 8712434

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl 1 microgram/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 1 microgram/kg
Number of subjects: 8
Study: 1986567

Group type: COMPARATOR
Intervention: EPO alone (2,000 U IV three times a week)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: EPO (2,000 U IV three times a week) + nandrolone decanoate (100 mg IM weekly)
Number of subjects: 15
Study: 6834370

Group type: EXPERIMENTAL
Intervention: 5 mg pindolol
Number of subjects: 30
Study: 31338545

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced high-protein (CRHP) diet
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional diabetes (CD) diet
Number of subjects: 28
Study: 30428891

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) - two sessions
Number of subjects: 162

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) - typical daily clinical practice
Number of subjects: 162
Study: 26873452

Group type: EXPERIMENTAL
Intervention: Food addiction group (after sad mood induction)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Food addiction group (before sad mood induction)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (after sad mood induction)
Number of subjects: 66
Study: 25262567

Group type: EXPERIMENTAL
Intervention: Injectable diacetylmorphine (DAM) or hydromorphone (HDM)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Oral methadone maintenance treatment (MMT)
Number of subjects: 29
Study: 21798873

Group type: EXPERIMENTAL
Intervention: Home interview
Number of subjects: 450

Group type: COMPARATOR
Intervention: Research office interview
Number of subjects: 450
Study: 20082055

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 576

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 576
Study: 17327536

Group type: EXPERIMENTAL
Intervention: Intervention group (toileting and walking assistance)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study: 14691709

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 517

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 517
Study: 11748952

Group type: EXPERIMENTAL
Intervention: Micronised purified flavonoid fraction (MPFF) 500 mg twice daily for 60 days
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo 500 mg twice daily for 60 days
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Micronised purified flavonoid fraction (MPFF) in patients with edema
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo in patients with edema
Number of subjects: 101
Study: 9709879

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD) 4 mg/(kg.d)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Amphotericin B 0.8 mg/(kg.d)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Amphotericin B colloidal dispersion (ABCD)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Amphotericin B
Number of subjects: 213
Study: 7654480

Group type: EXPERIMENTAL
Intervention: Microemulsion formulation of cyclosporin (Neoral), 10 mg kg‐1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional oral formulation of cyclosporin (Sandimmun), 10 mg kg‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Microemulsion formulation of cyclosporin (Neoral)
Number of subjects: 8
Study: 2566161

Group type: EXPERIMENTAL
Intervention: Xamoterol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 364615

Group type: EXPERIMENTAL
Intervention: Ketoprofen (50+50+100 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Naproxen (250+250+250 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ketoprofen
Number of subjects: 28

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ketoprofen and Naproxen
Number of subjects: 28
Study: 31850976

Group type: EXPERIMENTAL
Intervention: Compression stockings for 7 days
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Compression stockings for 7 days (with concurrent phlebectomies)
Number of subjects: 206

Group type: COMPARATOR
Intervention: No compression stockings
Number of subjects: 206

Group type: COMPARATOR
Intervention: Both groups (compression and no compression)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 206
Study: 29654563

Group type: EXPERIMENTAL
Intervention: Triple antibiotic paste (TAP) with minocycline
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: TAP with amoxicillin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: TAP with cefaclor
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: TAP with doxycycline
Number of subjects: 120

Group type: COMPARATOR
Intervention: No filling (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Internal bleaching with hydrogen peroxide (H2O2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Internal bleaching with H2O2 plus Nd‐YAG laser irradiation
Number of subjects: 120
Study: 28162785

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane block + systemic analgesia (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Systemic analgesia (Group 2)
Number of subjects: 40
Study: 26275900

Group type: EXPERIMENTAL
Intervention: Previous weight
Number of subjects: 2811

Group type: EXPERIMENTAL
Intervention: Change in step count
Number of subjects: 2811

Group type: EXPERIMENTAL
Intervention: Previous weight measurements
Number of subjects: 2811

Group type: EXPERIMENTAL
Intervention: Previous step count
Number of subjects: 2811